Conversion surgery for hepatocellular carcinoma with portal vein tumor thrombus after successful atezolizumab plus bevacizumab therapy: a case report

BACKGROUND: The treatment of hepatocellular carcinoma (HCC) requires diverse and multidisciplinary approaches. In recent years, new agents with good antitumor effects have emerged for systemic chemotherapy, and conversion surgery (CS) after systemic chemotherapy is expected to be an effective treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Hidaka, Yoshifumi, Tomita, Miyo, Desaki, Ryosuke, Hamanoue, Masahiro, Takao, Sonshin, Kirishima, Mari, Ohtsuka, Takao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277871/
https://www.ncbi.nlm.nih.gov/pubmed/35831894
http://dx.doi.org/10.1186/s12957-022-02691-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277871/
https://www.ncbi.nlm.nih.gov/pubmed/35831894
http://dx.doi.org/10.1186/s12957-022-02691-2

Ejemplares similares